Skip to content

Author

I. Augustin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Microbiome–Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma

Collectively, microbiome-based approaches may contribute to the development of personalized immunotherapeutic strategies in HCC, although larger standardized prospective studies are required before microbiome-derived biomarkers can be implemented in routine clinical practice.

Mădălina-Raluca Ostafe, S. Volovat, Ana Clement et al. · 0 citations
Review Open access Sep 2026

Circulating MicroRNAs in non-small cell lung cancer: Clinical potential, analytic pitfalls, and barriers to implementation

Background Neoadjuvant chemoimmunotherapy is standard care for resectable non-small cell lung cancer (NSCLC), yet 70% to 80% of patients do not achieve a pathologic complete response, and no validated biomarker identifies likely non-responders before or during treatment. Circulating microRNAs (miRNAs) have been propose...

I. Augustin, Adelina Birceanu, L. Mazilu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.